Filing Flows › DataMeds AI (MEDS) › Q4 2025
DataMeds AI (MEDS) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 20, 2026
DataMeds AI (MEDS) reported revenue of $1.7M for the fourth quarter 2025 (Q4 2025), -87% from a year earlier and -45% from the quarter before.
DataMeds AI, Q4 2025: revenue $1.7M (-86% year over year), net loss $27.9M, operating cash flow −$6.3M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | -45% | -87% |
| Operating profit | −$25.4M | — | — |
| Net earnings | −$27.9M | — | — |
| Operating cash flow | −$6.3M | — | — |
What changed
Revenue was $1.7M in Q4 2025, down 87% year over year and down 45% from the previous quarter. Product was the largest line at 61% of revenue.
Operating costs exceeded revenue by $25.4M, an operating margin of -1517.5%. The fastest-growing cost line was Other operating costs (+1964%). The quarter ended with a net loss of $27.9M, narrower than the previous quarter's $34.3M loss.
Operating cash flow was −$6.3M. Non-cash charges added back $803K of depreciation and amortization and $356K of share-based compensation. Working capital and other items added $20.4M.
Questions
What was DataMeds AI's revenue in the fourth quarter 2025?
DataMeds AI (MEDS) reported revenue of $1.7M for the fourth quarter 2025 (Q4 2025), -87% from a year earlier and -45% from the quarter before.
Source: DataMeds AI 10-K on SEC EDGAR.